NRXP ▼ -1.2% - NRx Pharmaceuticals, Inc. $NRXP - NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System NRx Pharmaceuticals' subsidiary HOPE Therapeutics has begun training and deployment of Zeta Surgical's FDA-cleared robotic transcranial magnetic stimulation (TMS) system, marking an expansion of the company's treatment capabilities. Despite this operational development, the stock declined 1.2% today. 11-SEP-2026 07:00 AM ET